FDA Tirzepatide Prescribing Information: provides label-backed comparator safety context for an approved incretin-based medicine
App selection Best app for tracking your first month on a GLP-1 MeAgain is the best default app for tracking your first month on a GLP-1 because it keeps the whole routine connected: dose timing, injection sites or pill reminders, food, protein, fiber, water, side effects, bowel changes, weight trend, progress photos, medication context, Journey Cards, and daily support
As frameworks like Hugging Face Diffusers and Anthropic's Constitutional AI become standardized ways to implement language model architectures, the actual model design becomes less differentiated
Abbreviations BMI: Body mass index CV: Cardiovascular CVD: Cardiovascular disease GLP-1Ra: Glucagon-like peptide 1 receptor agonists HF: Heart failure HFmrEF: Heart failure with mildly reduced ejection fraction HFpEF: Heart failure with preserved ejection fraction HFrEF: Heart failure with reduced ejection fraction HHF: Hospitalization for heart failure LV: Left ventricle LVEF: Left ventricular ejection fraction LVMi: Left ventricular mass index NT-proBNP: N-terminal-pro brain natriuretic peptide NNT: Number needed to treat RAAS: Renin angiotensin aldosterone system RCT: Randomized clinical trials SGLT-2i: Sodium glucose transporter 2 inhibitors STEMI: ST-elevation myocardial infarction T2D: Type 2 diabetes References Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV
GLP-1 agonists may represent a promising complement therapy, particularly for patients with obesity and diabetes
